Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560898 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function
A Phase 4 study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00560898 is a Phase 4 study that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 25 participants.
The verdict
NCT00560898, a Phase 4 study, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal barrier function following wear of two contact lens materials and two contact lens care systems, approved for marketing in the US by the Food and Drug Administration. These contact lenses will be worn for two hours, following soak in one of two marketed contact lens disinfecting solutions. Approximately 25 young, adapted contact lens wearers will participate.
Interventions
- DRUG ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution
- DRUG Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution
- DRUG Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution
- DRUG ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560898
The ClinicalTrials.gov registry entry for NCT00560898 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution is the first listed.
NCT00560898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560898 about?
NCT00560898 is a clinical study titled "Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function". The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal ...
What is the current status of trial NCT00560898?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2007-09. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00560898?
The interventions under investigation include: ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution (DRUG), Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution (DRUG), Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution (DRUG), ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution (DRUG).
Who is sponsoring clinical trial NCT00560898?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.